These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 16333312
1. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition. Vahteristo P, Syrjäkoski K, Heikkinen T, Eerola H, Aittomäki K, von Smitten K, Holli K, Blomqvist C, Kallioniemi OP, Nevanlinna H. Eur J Hum Genet; 2006 Feb; 14(2):167-72. PubMed ID: 16333312 [Abstract] [Full Text] [Related]
2. The BARD1 Cys557Ser variant and breast cancer risk in Iceland. Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K. PLoS Med; 2006 Jul; 3(7):e217. PubMed ID: 16768547 [Abstract] [Full Text] [Related]
3. Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. Karppinen SM, Barkardottir RB, Backenhorn K, Sydenham T, Syrjäkoski K, Schleutker J, Ikonen T, Pylkäs K, Rapakko K, Erkko H, Johannesdottir G, Gerdes AM, Thomassen M, Agnarsson BA, Grip M, Kallioniemi A, Kere J, Aaltonen LA, Arason A, Møller P, Kruse TA, Borg A, Winqvist R. J Med Genet; 2006 Nov; 43(11):856-62. PubMed ID: 16825437 [Abstract] [Full Text] [Related]
4. BARD1 and breast cancer in Poland. Jakubowska A, Cybulski C, Szymańska A, Huzarski T, Byrski T, Gronwald J, Debniak T, Górski B, Kowalska E, Narod SA, Lubiński J. Breast Cancer Res Treat; 2008 Jan; 107(1):119-22. PubMed ID: 17333333 [Abstract] [Full Text] [Related]
6. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer]. Liu WL, Zhao JZ, Wang ZZ, Dong B, Hou YY, Wu XX, Guo YJ. Zhonghua Fu Chan Ke Za Zhi; 2017 Jun 25; 52(6):403-410. PubMed ID: 28647964 [Abstract] [Full Text] [Related]
7. Lack of association between BARD1 Cys557Ser variant and breast cancer risk: a meta-analysis of 11,870 cases and 7,687 controls. Ding DP, Zhang Y, Ma WL, He XF, Wang W, Yu HL, Guo YB, Zheng WL. J Cancer Res Clin Oncol; 2011 Oct 25; 137(10):1463-8. PubMed ID: 21809034 [Abstract] [Full Text] [Related]
8. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer. Sauer MK, Andrulis IL. J Med Genet; 2005 Aug 25; 42(8):633-8. PubMed ID: 16061562 [Abstract] [Full Text] [Related]
9. The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case-control and family analysis. Johnatty SE, Beesley J, Chen X, Hopper JL, Southey MC, Giles GG, Goldgar DE, Chenevix-Trench G, Spurdle AB, Australian Ovarian Cancer Study Group, Kathleen Cuningham Consortium for Research in Familial Breast Cancer. Breast Cancer Res Treat; 2009 May 25; 115(1):145-50. PubMed ID: 18481171 [Abstract] [Full Text] [Related]
14. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis. Huo X, Hu Z, Zhai X, Wang Y, Wang S, Wang X, Qin J, Chen W, Jin G, Liu J, Gao J, Wei Q, Wang X, Shen H. Breast Cancer Res Treat; 2007 May 25; 102(3):329-37. PubMed ID: 17028982 [Abstract] [Full Text] [Related]
15. ATM variants and cancer risk in breast cancer patients from Southern Finland. Tommiska J, Jansen L, Kilpivaara O, Edvardsen H, Kristensen V, Tamminen A, Aittomäki K, Blomqvist C, Børresen-Dale AL, Nevanlinna H. BMC Cancer; 2006 Aug 16; 6():209. PubMed ID: 16914028 [Abstract] [Full Text] [Related]
16. Mutational analysis of BARD1 in familial breast cancer patients in Japan. Ishitobi M, Miyoshi Y, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S. Cancer Lett; 2003 Oct 08; 200(1):1-7. PubMed ID: 14550946 [Abstract] [Full Text] [Related]
17. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer. Gorringe KL, Choong DY, Visvader JE, Lindeman GJ, Campbell IG. Breast Cancer Res Treat; 2008 Oct 08; 111(3):505-9. PubMed ID: 17972171 [Abstract] [Full Text] [Related]
18. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Spurdle AB, Marquart L, McGuffog L, Healey S, Sinilnikova O, Wan F, Chen X, Beesley J, Singer CF, Dressler AC, Gschwantler-Kaulich D, Blum JL, Tung N, Weitzel J, Lynch H, Garber J, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Conroy D, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Selkirk CG, Daly M, Isaacs C, Stoppa-Lyonnet D, Sinilnikova OM, Buecher B, Belotti M, Mazoyer S, Barjhoux L, Verny-Pierre C, Lasset C, Dreyfus H, Pujol P, Collonge-Rame MA, GEMO Study Collaborators, Rookus MA, Verhoef S, Kriege M, Hoogerbrugge N, Ausems MG, van Os TA, Wijnen J, Devilee P, Meijers-Heijboer HE, Blok MJ, Heikkinen T, Nevanlinna H, Jakubowska A, Lubinski J, Huzarski T, Byrski T, Durocher F, Couch FJ, Lindor NM, Wang X, Thomassen M, Domchek S, Nathanson K, Caligo M, Jernström H, Liljegren A, Ehrencrona H, Karlsson P, SWE-BRCA, Ganz PA, Olopade OI, Tomlinson G, Neuhausen S, Antoniou AC, Chenevix-Trench G, Rebbeck TR. Cancer Epidemiol Biomarkers Prev; 2011 May 08; 20(5):1032-8. PubMed ID: 21393566 [Abstract] [Full Text] [Related]
19. Cancer predisposing BARD1 mutations in breast-ovarian cancer families. Ratajska M, Antoszewska E, Piskorz A, Brozek I, Borg Å, Kusmierek H, Biernat W, Limon J. Breast Cancer Res Treat; 2012 Jan 08; 131(1):89-97. PubMed ID: 21344236 [Abstract] [Full Text] [Related]
20. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Thai TH, Du F, Tsan JT, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, Bowcock AM. Hum Mol Genet; 1998 Feb 08; 7(2):195-202. PubMed ID: 9425226 [Abstract] [Full Text] [Related] Page: [Next] [New Search]